DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

TriGuard HDH

TAVI with the TriGuard HDH embolic deflection device

Trial Locations (14)

59000

Chru-Lille, Lille

Unknown

Hôpital de la Cavale Blanche, Brest

Clinique chez APHM, Marseille

Praxisklinik Herz Und Gefässe, Dresden

Universitäts-Herzzentrum Freiburg, Freiburg im Breisgau

Medical Care Center, Hamburg

Städtische Kliniken Neuss, Neuss

Rambam Medical Center, Haifa

Shaarey Tzedek, Jerusalem

Ferrarotto hospital, Catania

UMC Utrecht, Utrecht

Royal Sussex County Hospital, Brighton

Bristol Heart Institute, Bristol

Leeds General Infirmary, Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Keystone Heart

INDUSTRY